Wed, Aug 20, 2014, 3:18 PM EDT - U.S. Markets close in 42 mins.

Recent

% | $
Quotes you view appear here for quick access.

Pluristem Therapeutics, Inc. Message Board

  • iminjim iminjim Nov 9, 2012 12:43 PM Flag

    Article " Person Wasn't Even In The Clinical Study,Treated Compassion,On Death Bed" LINK

    Charles Gross, Benzinga Staff Writer
    November 08, 2012 9:31 PM
    Pluristem Therapeutics (NASDAQ: PSTI [FREE Stock Trend Analysis]) offered comments on an article published in Bloomberg on November 7, 2012. Pluristem has submitted a direct request to Bloomberg to publish a correction because the article it published is factually inaccurate and misleading.
    The subject of the article was a pediatric patient who was critically ill, in imminent danger of death and who had exhausted all other treatments. The patient was treated on a compassionate use basis in Israel, and was not part of Pluristem's ongoing clinical program. The patient was able to leave the hospital and survived six months, the last four of them in her home country of Romania. Pluristem was not monitoring the patient and learned of her death at the discretion of her family and physician. In addition, the formal report relating to the death clearly stated that there was no connection between the PLX cell treatment and the death of the patient.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
PSTI
2.62-0.02(-0.76%)3:17 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.